are compounded glp 1 drugs safe Have patients been harmed by unsafe drug compounding? – Partnership for Medicines Patients struggle as compounded GLP-1

GLP-1 can control the secretion of various neurotransmitters, the progression of neuroinflammation, and the increase in insulin sensitivity in the brain (Athauda and Foltynie, 2016)

With the thought that GLP-1s would help resolve health disparities, differences in ability to pay may deepen existing health disparities and prevent marginalized communities from benefiting from these potentially life-changing drugs

All patients receive full demonstration and supervision within the clinic prior to home use

Clinical studies have demonstrated significant weight loss achieved by semaglutide in individuals without diabetes, making it a valuable potential treatment option for patients struggling with obesity

Further, it is worth highlighting that survodutide is likely to drive the market in the near future